| 4DS Memory Limited (4DS) ORDINARY FULLY PAID |
Information Technology |
$23 |
imec shipment of Sixth Platform Lot
|
28 Apr 2025 9:06AM |
$0.028 |
$0.011 |
fallen by
60.71%
|
|
| Resimac Group Limited (RMC) ORDINARY FULLY PAID |
Financials |
$380 |
Update - Notification of buy-back - RMC
|
28 Apr 2025 9:05AM |
$0.850 |
$0.960 |
risen by
12.94%
|
|
| Pengana Global Private Credit Trust (PCX) ORDINARY UNITS FULLY PAID |
Financials |
$238 |
Update - Notification of buy-back - PCX
|
28 Apr 2025 9:05AM |
$1.980 |
$2.050 |
risen by
3.54%
|
|
| Elementos Limited (ELT) ORDINARY FULLY PAID |
Materials |
$105 |
Oropesa Tin Project DFS & Ore Reserve Presentation - Updated
|
28 Apr 2025 9:04AM |
$0.076 |
$0.315 |
risen by
314.47%
|
|
| Zeotech Limited (ZEO) ORDINARY FULLY PAID |
Materials |
$165 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
28 Apr 2025 9:04AM |
$0.079 |
$0.080 |
risen by
1.27%
|
|
ZEO - Price-sensitive ASX Announcement
Full Release
Key Points
- Zeotech Limited (ZEO) released its Quarterly Activities and Appendix 5B Cash Flow Report covering the period ending 31 March 2024.
- ZEO continued the advancement of its kaolin and zeolite-based mineral technology projects, focusing on the commercialisation of manufactured zeolites.
- Key activities included progressing the renewable energy-based zeolite manufacturing project and advancing pilot plant operations to scale up the production process.
- The company reported updates on its collaboration with the University of Queensland and Cooperative Research Centre for Contamination Assessment and Remediation of the Environment (CRC CARE) for product development and environmental applications.
- Zeotech continued its research and development in areas including PFAS remediation, emissions management, and agricultural applications for its zeolite products.
- During the quarter, the company secured additional intellectual property rights relating to its proprietary zeolite manufacturing technology.
- Cash outflows were primarily attributed to research and development, staff costs, and operational expenses linked to project advancement.
- The company ended the quarter with a strong cash position and no significant financing activities, indicating prudent financial management.
- Significant attention was given to the ongoing pilot plant operations, which are seen as pivotal to ZEO's near-term commercialisation strategy.
- ZEO highlighted plans for the next quarter, including further pilot plant optimisation, commercial partnership development, and expanded product application trials.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| AMCIL Limited (AMH) ORDINARY FULLY PAID |
Financials |
$319 |
Update - Notification of buy-back - AMH
|
28 Apr 2025 9:04AM |
$1.050 |
$1.010 |
fallen by
3.81%
|
|
| Bowen Coking Coal Limited (BCB) ORDINARY FULLY PAID |
Materials |
$8 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
28 Apr 2025 9:04AM |
$0.320 |
$0.075 |
fallen by
76.56%
|
|
BCB - Price-sensitive ASX Announcement
Full Release
Key Points
- Coal shipments commenced from the Burton Complex, marking a key operational milestone.
- Bluff Mine achieved a significant increase in production and sales volume.
- Exploration and development activities continued across other tenements, including Broadmeadow East, Isaac River, and Hillalong.
- Strategic partnerships and offtake agreements supported operational and financial progress.
- The company reported a quarter-on-quarter increase in revenue from coal sales.
- Operational cash flow turned positive, indicating improved financial performance.
- Significant investments were made in mine development, equipment, and infrastructure.
- The report details cash flows, including receipts, payments, investing, and financing activities.
- Bowen continues active cost management and capital discipline across its operations.
- At the end of the quarter, the company disclosed its cash balance and financial position.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Rimfire Pacific Mining Limited (RIM) ORDINARY FULLY PAID |
Materials |
$41 |
Notice of General Meeting/Proxy Form
|
28 Apr 2025 9:04AM |
$0.023 |
$0.015 |
fallen by
34.78%
|
|
| PYC Therapeutics Limited (PYC) ORDINARY FULLY PAID |
Health Care |
$965 |
Presentation of Clinical Proof of Concept in Lead Program
|
28 Apr 2025 9:02AM |
$1.115 |
$1.655 |
risen by
48.43%
|
|
PYC - Price-sensitive ASX Announcement
Full Release
Key Points
- PYC Therapeutics presented clinical proof of concept for VP-001 in PRPF31-mediated Retinitis Pigmentosa.
- VP-001 is an RNA-based therapy designed to correct the underlying genetic defect in patients.
- Early clinical trial data demonstrate a favorable safety profile for VP-001.
- Biological activity was observed in initial trial participants, indicating potential therapeutic benefit.
- The company emphasized the unmet need in inherited retinal diseases and the lack of approved therapies for this condition.
- Clinical trial design included measurement of safety, tolerability, and biomarkers of efficacy.
- VP-001 is administered via intravitreal injection, a standard ophthalmic delivery route.
- PYC outlined its strategic vision to expand its pipeline of precision RNA therapies for ophthalmology.
- The company aims to leverage its platform to address additional genetic eye diseases.
- PYC Therapeutics plans to continue advancing VP-001 through clinical development and regulatory engagement.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Butn Limited (BTN) ORDINARY FULLY PAID |
Financials |
$30 |
Quarterly Appendix 4C Cash Flow Report
|
28 Apr 2025 9:02AM |
$0.099 |
$0.078 |
fallen by
21.21%
|
|
BTN - Price-sensitive ASX Announcement
Full Release
Key Points
- Butn Limited reported strong year-on-year revenue growth for the quarter ended 31 March 2023.
- Total cash receipts from customers were $153.3 million, representing a 29% increase versus the prior corresponding period.
- Net cash used in operating activities was $0.4 million for the quarter.
- Payments to suppliers and employees totaled $2 million.
- There was ongoing investment in technology and operational capabilities.
- The company’s balance sheet was strengthened through prudent cash flow management.
- No significant related party transactions occurred other than director remuneration.
- The company remains focused on expanding product offerings and partnerships.
- Management commentary included risk assessment and outlook for future quarters.
- The report was lodged with the ASX on 28 April 2023.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Butn Limited (BTN) ORDINARY FULLY PAID |
Financials |
$30 |
Quarterly Activities Report
|
28 Apr 2025 9:01AM |
$0.099 |
$0.078 |
fallen by
21.21%
|
|
BTN - Price-sensitive ASX Announcement
Full Release
Key Points
- Record quarterly originations and cash receipts achieved.
- Strong growth in transaction volume and revenue compared to previous periods.
- Expansion of technology platforms and product offerings, including the launch of Butn X.
- Strengthened strategic partnerships, notably with MYOB.
- Improved funding efficiency and capital management.
- Enhanced customer acquisition and retention metrics.
- Operational focus on scalable technology and automation.
- Positive outlook supported by a strengthened balance sheet and growth initiatives.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Bapcor Limited (BAP) ORDINARY FULLY PAID |
Consumer Discretionary |
$703 |
Investor Strategy Update Presentation
|
28 Apr 2025 9:00AM |
$4.900 |
$2.070 |
fallen by
57.76%
|
|
BAP - Price-sensitive ASX Announcement
Full Release
Key Points
- Bapcor is hosting an Investor Strategy Update Presentation on 28 April 2025.
- The presentation focuses on Bapcor's growth strategy and operational updates.
- Key strategic priorities include optimizing retail and wholesale operations.
- Enhancing customer experiences and digitalization are major focus areas.
- The company aims to improve supply chain efficiencies.
- Market trends favoring aftermarket parts are acknowledged.
- A commitment to safety and performance improvement is emphasized.
- The leadership team was introduced during the presentation.
- Bapcor aims to maximize shareholder value through strategic initiatives.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Bhagwan Marine Limited (BWN) ORDINARY FULLY PAID |
Industrials |
$131 |
Further Strengthens Leadership Team with Appointment of COO
|
28 Apr 2025 8:59AM |
$0.420 |
$0.475 |
risen by
13.10%
|
|
| iTech Minerals Ltd (ITM) ORDINARY FULLY PAID |
Materials |
$12 |
Quarterly Activities and Cashflow Report 31 March 2025
|
28 Apr 2025 8:58AM |
$0.046 |
$0.050 |
risen by
8.70%
|
|
ITM - Price-sensitive ASX Announcement
Full Release
Key Points
- iTech Minerals Ltd released its Quarterly Activities and Cashflow Report for the quarter ending 31 March 2025.
- The company continued to progress its exploration activities across several key projects, with a focus on graphite, kaolin, and rare earth elements.
- Exploration during the quarter was primarily centered on the Campoona Graphite Project, where further drilling and metallurgical work were undertaken to advance the project toward development.
- Additional work on the Eyre Peninsula Kaolin Project included resource drilling and testwork to evaluate quality and potential of the kaolin deposits.
- Rare earth element (REE) exploration continued at the Caralue Bluff Project, with encouraging results from sampling and preliminary analysis.
- The company reported cash outflows related to exploration and evaluation activities, staff costs, and other administrative expenses.
- iTech Minerals ended the quarter with a strong cash position, providing sufficient funds to support ongoing exploration and development activities.
- No production or sales were reported during the quarter as projects remain in exploration and development phases.
- The report outlines the company’s continued focus on value creation through project advancement and exploring opportunities for strategic partnerships.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Papyrus Australia Limited (PPY) ORDINARY FULLY PAID |
Materials |
$6 |
Contract for Rapid Prototype and R&D Facility with UniSA
|
28 Apr 2025 8:58AM |
$0.013 |
$0.009 |
fallen by
30.77%
|
|
| Frontier Digital Ventures Limited (FDV) ORDINARY FULLY PAID |
Communication Services |
$113 |
1Q 2025 Trading Update
|
28 Apr 2025 8:58AM |
$0.280 |
$0.260 |
fallen by
7.14%
|
|
FDV - Price-sensitive ASX Announcement
Full Release
Key Points
- FDV delivered record revenue and EBITDA for 1Q 2025.
- Strong performance from core operating companies drove results.
- Marketplaces segment showed significant growth and improved monetization.
- Operational efficiency and cost management were key contributors to profitability.
- Strategic investments continued in technology and product development.
- Disciplined capital allocation and a focus on sustainable growth were emphasized.
- FDV remains well positioned for further growth through digital transformation initiatives.
- The company maintains a positive outlook for the remainder of 2025.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Sayona Mining Limited (SYA) ORDINARY FULLY PAID |
Materials |
- |
Moblan Drilling Results
|
28 Apr 2025 8:56AM |
$0.019 |
$3.440 |
risen by
18,005.26%
|
|
SYA - Price-sensitive ASX Announcement
Full Release
Key Points
- Sayona Mining Limited released new lithium assay results from the Moblan Lithium Project.
- The drilling campaign targeted both in-pit and near-resource growth zones.
- Significant intercepts reported include 92.0m at 1.69% Li2O and 127.2m at 1.55% Li2O.
- High-grade lithium mineralization remains open in several directions.
- Results indicate substantial resource growth potential at Moblan.
- The new data will contribute to future resource updates and ongoing feasibility studies.
- Moblan is positioned as a strategic lithium asset for North America.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Orthocell Limited (OCC) ORDINARY FULLY PAID |
Health Care |
$294 |
Remplir Approved to Commence Sales in US$84M Thai Market
|
28 Apr 2025 8:55AM |
$1.290 |
$1.085 |
fallen by
15.89%
|
|
OCC - Price-sensitive ASX Announcement
Full Release
Key Points
- Orthocell Limited receives approval to sell Remplir in Thailand.
- Remplir is a collagen medical device for peripheral nerve repair.
- The Thai market for peripheral nerve repair is valued at US$84 million.
- Device Technologies will commercialize Remplir in Thailand.
- First orders for Remplir in Thailand expected in Q3 2024.
- Remplir is already approved in Australia, New Zealand, the UK, and Europe.
- Approval in Thailand is an important step in Orthocell's international expansion strategy.
- Remplir aids in the regeneration of severed or damaged peripheral nerves.
- Orthocell aims to be a leader in regenerative medicine products.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Sierra Nevada Gold Inc. (SNX) CDI 1:1 US PERSON PROHIBITED EXCLUDING QIB |
Materials |
$16 |
Notification of cessation of securities - SNX
|
28 Apr 2025 8:55AM |
$0.017 |
$0.032 |
risen by
88.24%
|
|
| PhosCo Ltd (PHO) ORDINARY FULLY PAID |
Materials |
$75 |
Operational Update and Entitlement Offer Reminder
|
28 Apr 2025 8:55AM |
$0.046 |
$0.155 |
risen by
236.96%
|
|
| nanollose Limited (NC6) ORDINARY FULLY PAID |
Health Care |
$16 |
Pilot Production Of Wool/Nullarbor Blankets Completed By Wav
|
28 Apr 2025 8:55AM |
$0.046 |
$0.049 |
risen by
6.52%
|
|
| Narryer Metals Limited (NYM) ORDINARY FULLY PAID |
Materials |
$5 |
Director Resignation
|
28 Apr 2025 8:55AM |
$0.031 |
$0.031 |
fallen by
0%
|
|
| Viva Leisure Limited (VVA) ORDINARY FULLY PAID |
Consumer Discretionary |
$163 |
Update - Notification of buy-back - VVA
|
28 Apr 2025 8:54AM |
$1.290 |
$1.655 |
risen by
28.29%
|
|
| FFI Holdings Limited (FFI) ORDINARY FULLY PAID |
Consumer Staple |
$65 |
Change of Director's Interest Notice
|
28 Apr 2025 8:53AM |
$4.090 |
$4.830 |
risen by
18.09%
|
|
| Clearview Wealth Limited (CVW) ORDINARY FULLY PAID |
Financials |
$346 |
Update - Notification of buy-back - CVW
|
28 Apr 2025 8:53AM |
$0.450 |
$0.550 |
risen by
22.22%
|
|
Call 1300 880 160
Start a chat
Schedule a call
